Micrillon, a new microfibre additive made by UMF Corporation of Skokie, Illinois, is setting a new standard in hospital-grade microfibres that can be converted into a wide range of long-lasting, reusable products, including towels, cubicle curtains, socks, gloves, walk-off mats, reusable N95 rated face masks and colour-coded microfibre cleaning products.

Leading manufacturers are using these high performance microfibres in materials targeting infection prevention in hospitals, hotels, cruise lines, long term care, and many other industries.

“The introduction of Micrillon microfibre puts an end, once and for all, to any question about recontamination related to reusable products,” said UMF Corporation CEO George Clarke. “Some manufacturers and distributors of disposable products – including cubicle curtains, microfibre mops, and wipers – have generated controversy around the risk of reusable products, such as microfibre wipers recontaminating a patient room, even after being laundered. This ignores the fact that after laundering, wipers used in hospitals are immersed in an EPA-registered disinfectant before use – effectively killing bacteria and inactivating viruses.”

Micrillon is a rechargeable polymer additive that can be incorporated into manmade fibres, films, and plastics and then charged with chlorine molecules. The chemistry recharges for the life of the product and will not leach into the environment. When microbes come into contact with a Micrillon surface, they are eliminated and viruses are inactivated.

 The range of Micrillon fibres, including sheath and core, bicomponent segmented pie, and hollow core segmented pie, demonstrate significant antiviral properties against Human Coronavirus, which causes Covid-19, and Human Influenza A H1N1 virus in just minutes. Micrillon also demonstrates 100% antibacterial elimination of Staphylococcus aureus (MRSA) and E. coli 0157:H7.

“UMF has dedicated significant time and resources developing the unrivaled Micrillon cleaning system,” added Clarke. “Micrillon products can physically remove everything from a surface and absorb it into the textile, where the disinfectant dwell time exceeds that required to inactivate and kill microbes. These durable, reusable products are cost effective and sustainable. They significantly reduce the burden on the medical products waste stream.”

“We had the opportunity to test Micrillon technology and our results demonstrated significant antimicrobial activity against various pathogens,” said Dr Mina Izadjoo, president and chief science officer at leading contract services organization Integrated Pharma Services. “Our testing and evaluation may lead to the advancement of much-needed infection control measures against hard-to-treat and drug-resistant pathogens.”

UMF also recently introduced Klorese, a private labelled disinfectant, now EPA-registered in all US 50 states. Klorese has broad spectrum effectiveness against Human Coronavirus, C. diff spores, Candida auris, MRSA and many additional bacteria, fungi, spores, viruses and mycobacteria. Together, Micrillon true colour-coded microfibre products and Klorese are all that is needed for hospital-grade, facility-wide, clinically acceptable cleaning and disinfection.

www.perfectclean.com